CIK 0001635088 · Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- operating
- EIN
- 981173944
- Phone
- 441-295-5950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- 144 Insider Sale of Securities
- 144/A Insider Sale of Securities
- 144/A Insider Sale of Securities
- 144/A Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale President & Immunovant CEO sold 200,000 shares at $36.31 ($7,262,000)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 4 Planned sale President & Immunovant CEO sold 200,000 shares at $36.59 ($7,318,000)
- 144 Insider Sale of Securities
- 4 Grant or award Director acquired 810 shares (grant or award)
- 4 Shares withheld for taxes Director gave up 116 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 77 shares (to pay taxes)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 1 of 51 · 1,008 filings